CLSH

CLS Holdings Inc.

Investment opportunity

Darling Capital LLC

 About CLS
CLS Holdings (“Cannabis Life Sciences”) is a company that acquires
cannabis producers, retailers and licenses.

CLS also has a proprietary technology for producing cannabis in which they
can extract a high yield of cannabinoids from a plant.

Recently, CLS acquired Oasis Cannabis, which is one of the top cannabis
licensees. CLS is in the process of building a processing facility and
projects $20 million in revenue after the first phase is complete.

The Cannabis market is now $6 billion and growing. CLS has tremendous
growth opportunity. The state of Nevada alone is projected to hit a $650
million market by 2020.

Darling Capital LLC

 Nevada Market
Nevada 6

Past and Projected Nevada Legal Sales of

$700.0
Cannabis (Millions $) $650.0
$600.0

$500.0
$500.0
Key Points
$400.0 $350.0
$300.0
Only 45 dispensary licenses issued in the greater Las Vegas
$200.0 $150.0
$100.0
area
$100.0 $50.0
$0.0 35 additional dispensary licenses available January 2018;
2015 2016 2017 2018 2019 2020
no more allowed until July 2019 at the earliest (per statute)

Expanding medical market

Recently passed adult use market, which went into effect

July 1, 2017

Source: Data from ArcView Market Research

Darling Capital LLC

Darling’s Past Success
Darling Capital has a phenomenal history of success with funding public
companies.

One such case is QBIO.

In December of 2015, Darling invested $300,000.00 with QBIO. As of

December 2017, Darling’s return is at an astounding $1,196,249.59 which
is a staggering 398.75% return on the initial investment.

In addition, Darling provided a second round of funding in the amount of

$520,000.00 to QBIO in July of 2017. The projected return of that deal
along with its warrants is approximately $1.2 million.

Darling Capital LLC

 The deal

 Darling receives a Convertible Note in the face value of the amount it funds.
The note accrues 8% interest. After six months, Darling can convert this
Note into free-trading shares of CLSH at $0.31 per share.
 Darling receives two warrants for every $1 it funds. Warrants are exercisable
at $0.75 per share. For example, if Darling funds $200,000, it would receive
400,000 warrants.

Darling Capital LLC

 Potential
Where could CLS be in the near future?

CLS is building out a processing facility for production of cannabis while the
market is simultaneously exploding and projected to grow 600% by 2020. For
reference, here are competing public companies and where their stock is at.
Whereas the companies listed below are in operation for a while, CLSH has not
even touched the tip of the iceberg in terms of potential. We project CLSH to
be between $2-$6 in six months.

• ACBFF has a 4.20 billion market cap. Their stock is at $9.70

• WEED has a 7.03 billion market cap. Their stock is at $36.78
• APH has a 3.3 billion market cap. Their stock is at $21.82

Darling Capital LLC

Reference Chart

Potential

$40.00

$35.00

$30.00

$25.00

$20.00

$15.00

$10.00

$5.00

$0.00
CLSH ACBFF APH WEED

Darling Capital LLC

 Conclusion:
Rare, Lucrative Opportunity
 Deal with CLSH is positioned in the right place at the right time.

 Profits may exceed projections.

 Opens a path to continued unique business with CLSH

Darling Capital LLC